Aleksovska, Katina

HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction

Paudel, Y. N., Shaikh, M. F., Chakraborti, A., Kumari, Y., Aledo-Serrano, Á., Aleksovska, K., Alvim, M. K. M., & Othman, I. (2018) · Frontiers in Neuroscience

Advanced Glycation End Products researchNeuroinflammation and Neurodegeneration Mechanisms

Cited by 311

Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor

Flacco, M. E., Manzoli, L., Boccia, S., Capasso, L., Aleksovska, K., Rosso, A., Scaioli, G., De Vito, C., Siliquini, R., Villari, P., et al. (2015) · Journal of Clinical Epidemiology

Pharmaceutical industry and healthcareStatistical Methods in Clinical Trials

Cited by 177

Joint European Academy of Neurology–European Pain Federation–Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment

Truini, A., Aleksovska, K., Anderson, C. C., Attal, N., Baron, R., Bennett, D. L., Bouhassira, D., Cruccu, G., Eisenberg, E., Enax‐Krumova, E., et al. (2023) · European Journal of Neurology

Pain Mechanisms and TreatmentsPain Management and Treatment

Cited by 113